Quadrature Capital’s AdaptHealth AHCO Stock Holding History

Quadrature Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,621	Closed	-$192K	–	839
2022 Q2	$192K	Buy	+10,621	New	+$172K	0.01%	631

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrature Capital's AHCO Position: Q3 2022 in Review

Quadrature Capital sold out of AdaptHealth (AHCO) in Q3 2022, closing a stake of 10,621 shares — an estimated $192K sold.

Quadrature Capital first reported a position in AHCO in Q2 2022 and held it in 1 quarter. The position peaked at $192K in Q2 2022. 184 funds tracked by Wall St. Rank hold AHCO as of Q3 2022.

Quadrature Capital reported no remaining AdaptHealth position as of Q3 2022 after selling out during the quarter.
Quadrature Capital sold 10,621 AdaptHealth shares in Q3 2022, an estimated $192K.
Quadrature Capital first reported a position in AdaptHealth in Q2 2022 and held it in 1 quarter.
Quadrature Capital's AdaptHealth position peaked at $192K in Q2 2022.
184 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2022.

Based on Quadrature Capital's 13F filing for Q3 2022, filed 14 Nov 2022.